Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a Meta-analysis

AIM: To systematically compare the efficacy and safety of off-label bevacizumab versus licensed ranibizumab intravitreal injections as well as monthly regimen versus pro re nata [PRN (as needed)] regimen in the treatment of neovascular age-related macular degeneration (nAMD). METHODS: Relevant publi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Ophthalmol
Hauptverfasser: Wang, Wen-Jie, Chen, Jian, Zhang, Xiao-Ling, Yao, Min, Liu, Xiao-Yong, Zhou, Qing, Qu, Yi-Xin
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Journal of Ophthalmology Press 2015
Schlagworte:
Informatics Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4325258/
https://ncbi.nlm.nih.gov/pubmed/25709924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3980/j.issn.2222-3959.2015.01.26
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge